Cargando…
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Glioblastoma (GBM) is a cancer type with high thrombogenic potential and GBM patients are therefore at a particularly high risk for thrombotic events. To date, only limited data on anticoagulation management after pulmonary embolism (PE) in GBM is available and the sporadic use of DOACs remains off-...
Autores principales: | Dubinski, Daniel, Won, Sae-Yeon, Voss, Martin, Keil, Fee, Miesbach, Wolfgang, Behmanesh, Bedjan, Dosch, Max, Baumgarten, Peter, Bernstock, Joshua D., Seifert, Volker, Freiman, Thomas M., Gessler, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827361/ https://www.ncbi.nlm.nih.gov/pubmed/33900495 http://dx.doi.org/10.1007/s10143-021-01539-9 |
Ejemplares similares
-
Incidence, risk factors and clinical course of pyogenic spondylodiscitis patients with pulmonary embolism
por: Dubinski, Daniel, et al.
Publicado: (2021) -
Therapeutic Anticoagulation Impacts MR Morphologic Recurrence Patterns in Glioblastoma—A Matched-Pair Analysis
por: Dubinski, Daniel, et al.
Publicado: (2022) -
Association of Isocitrate Dehydrogenase (IDH) Status With Edema to Tumor Ratio and Its Correlation With Immune Infiltration in Glioblastoma
por: Dubinski, Daniel, et al.
Publicado: (2021) -
Pulmonary embolism in neurocritical care-introduction of a novel grading system for risk stratification: the Frankfurt AMBOS score
por: Dubinski, Daniel, et al.
Publicado: (2020) -
Intracranial pressure monitoring in posterior fossa lesions—systematic review and meta-analysis
por: Won, Sae-Yeon, et al.
Publicado: (2022)